- Investing Ideas
- South Korean Pharmaceuticals & Biotech Sustainable Track Record
South Korean Pharmaceuticals & Biotech Sustainable Track Record
Results
6
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
6 companies
PharmaResearch
Market Cap: ₩4.1t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩394,500.00
7D
13.4%
1Y
-35.1%
Samsung BiologicsLtd
Market Cap: ₩70.1t
Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,514,000.00
7D
-0.9%
1Y
-4.3%
Oscotec
Market Cap: ₩1.4t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩35,350.00
7D
24.5%
1Y
13.3%
JW Shinyak
Market Cap: ₩130.2b
Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.
A067290
₩2,330.00
7D
28.7%
1Y
57.0%
JW Holdings
Market Cap: ₩263.6b
Operates as a healthcare company in South Korea, the United States, Japan, China, and internationally.
A096760
₩3,810.00
7D
4.1%
1Y
9.6%
SK Biopharmaceuticals
Market Cap: ₩6.5t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩83,500.00
7D
7.6%
1Y
-16.2%